FDA Adverse Event Other Summary report: N

INTROCAN SAFETY

MDR report key: 1120714 · Received August 14, 2008

Report

Report Number
2523676-2008-00071
Event Type
Other
Date Received
August 14, 2008
Date of Event
July 10, 2008
Report Date
August 7, 2008
Manufacturer
B. BRAUN MEDICAL, INC.
Product Code
FOZ
PMA / PMN Number
K982805
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

THE ACTUAL DEVICE IN THE INCIDENT HAS NOT YET BEEN RETURNED TO THE MFR TO BE EVALUATED. WITHOUT THE SAMPLE A THOROUGH EVAL COULD NOT BE PERFORMED. NO SPECIFIC CONCLUSIONS CAN BE DRAWN. IT WOULD BE NOTED THAT THE INTROCAN SAFETY IS DESIGNED TO REDUCE THE RISK OF NEEDLESTICK INJURIES. HOWEVER, CDC GUIDELINES AND/OR FACILITY PROTOCOLS SHOULD ALWAYS BE FOLLOWED. SHARPS SHOULD BE DISPOSED OF IMMEDIATELY INTO AN APPROPRIATE SHARPS CONTAINER. IT APPEARS FROM THE EVENT DESCRIPTION THAT THE PRODUCT FUNCTIONED PROPERLY, HOWEVER, THE NEEDLE WAS NOT DISPOSED OF IMMEDIATELY AND DURING CLEANUP THE NEEDLE CLIP WAS SOMEHOW MANIPULATED AND EXPOSED THE NEEDLE, RESULTING IN A NEEDLESTICK. ALL AVAILABLE INFO HAS BEEN PROVIDED TO THE ACTUAL MFR.

Description of Event or Problem · 1

AS REPORTED BY THE USER FACILITY: IV START UNSUCCESSFUL, THE STYLET WAS REMOVED FROM CATHETER, CLIP ENGAGED AT TIP, NURSE PLACED PRODUCT TO SIDE IN PACKAGING. WHEN PICKED UP, THE CLIP "WAS NOT ON THE END" OF THE STYLET. NURSE SUSTAINED NEEDLESTICK INJURY. FACILITY PROTOCOL FOLLOWED. PT WAS POSITIVE FOR (B) (6). ADDITIONAL INFO PROVIDED BY THE FACILITY INDICATED THE NURSE IN THE INCIDENT HAD INITIAL BASELINE BLOODWORK TESTING DONE. THE NURSE IS DUE TO HAVE 6 WEEK BLOODWORK TESTING PERFORMED. THERE WILL BE A 12 WEEK FOLLOW-UP TESTING AND 6 MONTH FOLLOW-UP TESTING PERFORMED. THE SAMPLE WILL BE SENT FOR EVAL BY THE SALES REP.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INTROCAN SAFETY I.V. SAFETY CATHETER FOZ B. BRAUN MEDICAL, INC. NA 8A14258306

Patients

Seq Age Sex Outcome Treatment
1 Other